Do you want to read an article? Please log in or register.
Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
Lung Cancer
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Quantitative Emphysema on Low-Dose Computed Tomography of the Chest and Risk of Lung Cancer and Airflow Obstruction: An analysis of the National Lung Screening Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Labaki WW, Xia M, Murray S, Hatt CR, Al-Abcha A, Ferrera MC, Meldrum CA, Keith LA, Galbán CJ, Arenberg DA, Curtis JL, Martinez FJ, Kazerooni EA, Han MK
doi: 10.1016/j.chest.2020.12.004
RECOMMENDED
Emphysema
The effect of radiographic emphysema in assessing lung cancer risk
Thorax.
Yong PC, Sigel K, de-Torres JP, Mhango G, Kale M, Kong CY, Zulueta JJ, Wilson D, Brown SW, Slatore C, Wisnivesky J
doi: 10.1136/thoraxjnl-
RECOMMENDED
Lung Cancer
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening
Clin Lung Cancer.
Tolwin Y, Gillis R, Agmon IN, Shrem NS, Rosenbaum E, Peled N
doi: 10.1016/j.cllc.2019.06.010.
RECOMMENDED
Lung Cancer
Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Lebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, Greaves M, Howells J, Irion K, Karunaratne D, Lyons J, Mellor S, Myerscough A, Newton T, Sharman A, Smith E, Taylor B, Taylor S, Walsham A, Whittaker J, Barber PV, Tonge J, Robbins HA, Booton R, Crosbie PAJ
doi: 10.1136/thoraxjnl-2020-214626.
RECOMMENDED
Pulmonary FibrosisLung Cancer
The Associations of Interstitial Lung Abnormalities with Cancer Diagnoses and Mortality
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Axelsson GT, Putman RK, Aspelund T, Gudmundsson EF, Hida T, Araki T, Nishino M, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G
doi: 10.1183/13993003.02154-2019.
RECOMMENDED
Lung Cancer
Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial
Chest.
Iaccarino JM, Silvestri GA, Wiener RS
doi: 10.1016/j.chest.2019.06.016.
RECOMMENDED
Lung Cancer
Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Tessema M, Tassew DD, Yingling CM, Do K, Picchi MA, Wu G, Petersen H, Randell S, Lin Y, Belinsky SA, Tesfaigzi Y
doi: 10.1016/j.lungcan.2020.05.017.
RECOMMENDED
Lung Cancer
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
N Engl J Med.
de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, Prokop M, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA, Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM, Oudkerk M, HypoEXIT Study Group
doi: 10.1056/NEJMoa1911793.
RECOMMENDED
Lung Cancer
Protocol and Rationale for the International Lung Screening Trial (ILST)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Am Thorac Soc.
Lim KP, Marshall H, Tammemägi M, Brims F, McWilliams A, Stone E, Manser R, Canfell K, Weber M, Connelly L, Bowman RV, Yang IA, Fogarty P, Mayo J, Yee J, Myers R, Atkar-Khattra S, Lam DC, Rosell A, Berg CD, Fong KM, Lam S, International Lung Screening Trial (ILST) Investigators.
doi: 10.1513/AnnalsATS.201902-102OC.